肝纤维化诊断及其严重程度评估*

doi:10.3969/j.issn.1672-5069.2017.01.005

Abstract

Hu Ye, Zhang Guo.. Diagnosis, severity assessment of hepatic fibrosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 13-16.

[1] Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol,2007,47（4）:598-607.
[2] Knodell RG,Ishak KG,Black WC,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology,1981,1（5）:431-435.
[3] Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis:the Knodell histology activity index and beyond. Hepatology,2000,31（1）:241-246.
[4] 王宝恩. 肝纤维化的诊断与严重度评估. 中华肝脏病杂志,1998,6（4）:193-194.
[5] Gaggini MC,Navarro RS,Stefanini AR,et al. Correlation between METAVIR scores and Raman spectroscopy in liver lesions induced by hepatitis C virus: a preliminary study. Lasers Med Sci,2015,30（4）:1347-1355.
[6] 郎振为. 病理学检测在慢性乙型肝炎诊断治疗中的价值. 世界华人消化杂志,2003,11（6）:772-774.
[7] 王松贤. 慢性乙型肝炎患者肝组织学检查的意义. 实用肝脏病杂志,2014,17（3）:297-298.
[8] 周红星. 慢性乙型肝炎临床和组织病理学诊断的对比研究. 中国医疗前沿,2013,8（23）:90-91.
[9] Chevallier M,Guerret S,Chossegros P,et al. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens:comparison with morphometric studies. Hepatology,1994,20（2）:349-355.
[10] 王泰龄,刘霞,周元平,等. 慢性肝炎炎症活动度及纤维化程度计分方案. 中华肝脏病杂志,1998,6（4）:195-197.
[11] Kleiner DE,Brunt EM,Van Natta M,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology,2005,41（6）:1313-1321.
[12] Ludwig J,Barham SS,LaRusso NF,et al. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology,1981,1（6）:632-640.
[13] Ludwig J,Dickson ER,McDonald GS. Staging of chronic nonsuppurative destructive cholangitis（syndrome of primary biliary cirrhosis）. Virchows Arch A Pathol Anat Histol,1978,379（2）:103-112.
[14] Banff schema for grading liver allograft rejection:an international consensus document. Hepatology,1997,25（3）:658-663.
[15] Xu S,Wang Y,Tai DC,et al. qFibrosis:a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients. J Hepatol,2014,61（2）:260-269.
[16] 梁携儿,汪艳,侯金林. 肝纤维化定量诊断: 有创还是无创?临床肝胆病杂志,2015,31（3）:317-321.
[17] Asselah T,Marcellin P,Bedossa P. Improving performance of liver biopsy in fibrosis assessment. J Hepatol,2014,61（2）:193-195.
[18] Wang Y,Hou JL. Current strategies for quantitating fibrosis in liver biopsy. Chin Med J （Engl）,2015,128（2）:252-258.
[19] Almpanis Z,Demonakou M,Tiniakos D. Evaluation of liver fibrosis:“Something old,something new……”. Ann Gastroenterol,2016,29（4）:445-453.
[20] Vuppalanchi R,Sanyal AJ. Myths and mysteries about staging hepatic fibrosis by fibroscan. Clin Gastroenterol Hepatol,2015,13（4）:780-782.
[21] European Association for Study of L,Asociacion Latinoamericana para el Estudio del H. EASL-ALEH Clinical Practice Guidelines:Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol,2015,63（1）:237-264.
[22] 瞬时弹性成像技术（TE）临床应用共识专家委员会. 瞬时弹性成像技术（TE）临床应用专家共识（2015年）. 中国肝脏病杂志（电子版）,2015,7（2）:12-18.
[23] Corpechot C,Gaouar F,El Naggar A,et al. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology,2014,146（4）: 970-979; quiz e915-976.
[24] 刘倚河,廖瑞真,秦青秀,等. 声辐射力脉冲成像技术对肝纤维化分级的应用价值. 临床军医杂志,2013,41（3）:300-303.
[25] 邓锡源,马苏美,李辉,等. ARFI技术与血清总胆汁酸在慢性丙型肝炎肝硬化Child-Pugh分级中的应用. 世界华人消化杂志,2016,24（2）:287-292.
[26] Su LN,Guo SL,Li BX,et al. Diagnostic value of magnetic resonance elastography for detecting and staging of hepatic fibrosis:a meta-analysis. Clin Radiol,2014,69（12）:e545-552.
[27] 杨明磊,姚定康. 磁共振弹性成像在肝纤维化无创诊断中的应用. 临床肝胆病杂志,2016,32（3）:588-592.
[28] Singh S,Venkatesh SK,Wang Z,et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis:a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol,2015,13（3）:440-451 e446.
[29] Singh S,Venkatesh SK,Loomba R,et al. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease:a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol,2016,26（5）: 1431-1440.
[30] Li B,Min J,Liang WR,et al. Use of magnetic resonance elastography for assessing liver functional reserve:A clinical study. World J Gastroenterol,2015,21（24）:7522-7528.
[31] Zeng DW,Dong J,Liu YR,et al. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World J Gastroenterol,2016,22（29）:6663-6672.
[32] Myers RP,Tainturier MH,Ratziu V,et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol,2003,39（2）:222-230.
[33] Hui AY,Chan HL,Wong VW,et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol,2005,100（3）: 616-623.
[34] Zeng MD,Lu LG,Mao YM,et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology,2005,42（6）:1437-1445.
[35] Zhou K,Gao CF,Zhao YP,et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol,2010,25（9）:1569-1577.
[36] Siddiqui MS,Patidar KR,Boyett S,et al. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease. Liver Int,2016,36（4）:572-579.
[37] Wong GL,Chan HL,Yu Z,et al. Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B. J Gastroenterol Hepatol,2015,30（3）:582-590.
[38] Wong GL,Wong VW,Choi PC,et al. Development of a non-invasive algorithm with transient elastography（Fibroscan） and serum test formula for advanced liver fibrosis in chronic hepatitis B. Aliment Pharmacol Ther,2010,31（10）:1095-1103.
[39] Liao R,Fu YP,Wang T,et al. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma:a retrospective cohort study at two centers in China. Oncotarget,2016（ahead of print）.
[40] Boursier J,de Ledinghen V,Zarski JP,et al. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C:new algorithms are more precise and entirely noninvasive. Hepatology,2012,55（1）:58-67.
[41] Castera L,Sebastiani G,Le Bail B,et al. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol,2010,52（2）:191-198.
[42] Boursier J,de Ledinghen V,Zarski JP,et al. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol,2011,106（7）:1255-1263.
[43] Attallah AM,El-Far M,Abdel Malak CA,et al. Fibro-check:a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients. Ann Hepatol,2015,14（2）:225-233.
[44] Liu Y,Dong CF,Yang G,et al. Optimal linear combination of ARFI,transient elastography and APRI for the assessment of fibrosis in chronic hepatitis B. Liver Int,2015,35（3）:816-825.

Diagnosis, severity assessment of hepatic fibrosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[4]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[5]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[6]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[7]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[8]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[9]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[10]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[11]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[12]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[13]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[14]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[15]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.